Drug search by name

Zanamivir and Asthma/COPD

Generic Name: zanamivir
Dosage Forms: n.a.
Other Brand Names: Relenza

Result of checking the interaction of drug Zanamivir and disease Asthma/COPD for safety when used together.

Check result:

Zanamivir <> Asthma/COPD

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Serious respiratory adverse events, including bronchospasm and/or decline in lung function, have been reported during clinical trials and postmarketing use of zanamivir. The manufacturer does not generally recommend its use in patients with underlying airways disease such as asthma or chronic obstructive pulmonary disease. However, if it is prescribed, these patients should have a fast-acting inhaled bronchodilator readily available whenever zanamivir is administered. The drug should be stopped and the physician notified in case of worsening respiratory symptoms. Patients scheduled to use an inhaled bronchodilator at the same time as the zanamivir dose should use their bronchodilator before administering zanamivir.

References: